SHANDY STOTLER: Open Payments
NPI 1588100408 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 25 payments from 11 companies in 2025. Trend: 2023 $698 · 2024 $847 · 2025 $759
Food & beverage: $664Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $207 |
| Astellas Pharma US Inc | 4 | $164 |
| Aveo Pharmaceuticals, Inc. | 5 | $133 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Dendreon Pharmaceuticals LLC | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| PFIZER INC. | 1 | $27 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
Products named: FOTIVDA, RYBREVANT, XTANDI, ERLEADA, KEYTRUDA, PROVENGE, Nubeqa, PYLARIFY.
Industry payments across OK — which companies pay providers there.
